UA89795C2 - Фармацевтическая композиция, которая содержит эстер темозоломида - Google Patents

Фармацевтическая композиция, которая содержит эстер темозоломида

Info

Publication number
UA89795C2
UA89795C2 UAA200704418A UAA200704418A UA89795C2 UA 89795 C2 UA89795 C2 UA 89795C2 UA A200704418 A UAA200704418 A UA A200704418A UA A200704418 A UAA200704418 A UA A200704418A UA 89795 C2 UA89795 C2 UA 89795C2
Authority
UA
Ukraine
Prior art keywords
compounds
pharmaceutical composition
temozolomide
pharmaceutical
ester
Prior art date
Application number
UAA200704418A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Йонфен Ван
Original Assignee
Тян Джин Тасли Групп Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тян Джин Тасли Групп Ко., Лтд. filed Critical Тян Джин Тасли Групп Ко., Лтд.
Publication of UA89795C2 publication Critical patent/UA89795C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
UAA200704418A 2004-09-22 2005-09-15 Фармацевтическая композиция, которая содержит эстер темозоломида UA89795C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2004100720564A CN1752088A (zh) 2004-09-22 2004-09-22 含有替莫唑胺酯的药用组合物

Publications (1)

Publication Number Publication Date
UA89795C2 true UA89795C2 (ru) 2010-03-10

Family

ID=36089840

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200704418A UA89795C2 (ru) 2004-09-22 2005-09-15 Фармацевтическая композиция, которая содержит эстер темозоломида

Country Status (20)

Country Link
US (1) US7579336B2 (enExample)
EP (1) EP1798234B1 (enExample)
JP (2) JP5620046B2 (enExample)
KR (1) KR101065984B1 (enExample)
CN (1) CN1752088A (enExample)
AR (1) AR050947A1 (enExample)
AU (1) AU2005287799B2 (enExample)
BR (1) BRPI0515555A (enExample)
CA (1) CA2580910C (enExample)
DK (1) DK1798234T3 (enExample)
ES (1) ES2389376T3 (enExample)
IL (1) IL182027A (enExample)
MX (1) MX2007003366A (enExample)
MY (1) MY153713A (enExample)
NZ (1) NZ554609A (enExample)
PL (1) PL1798234T3 (enExample)
RU (1) RU2393160C2 (enExample)
UA (1) UA89795C2 (enExample)
WO (1) WO2006032190A1 (enExample)
ZA (1) ZA200702801B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1727340B (zh) * 2004-07-29 2011-05-18 天津帝士力投资控股集团有限公司 一种替莫唑胺-8-羧酸酯及其组合物
EP1808173A1 (en) * 2006-01-12 2007-07-18 Matthias Dormeyer Use of CNS penetrating anticancer compounds for the treatment of protozan diseases
US8558511B2 (en) * 2009-04-07 2013-10-15 Battelle Memorial Institute Method and apparatus for smart battery charging including a plurality of controllers each monitoring input variables
KR20140087846A (ko) * 2012-12-31 2014-07-09 주식회사 삼양바이오팜 테모졸로미드를 포함하는 안정성이 개선된 약제학적 조성물 및 이의 제조방법
RU2527258C1 (ru) * 2013-02-19 2014-08-27 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" 6-ЗАМЕЩЕННЫЕ 3-АЗОЛИЛИМИДАЗО[1,2-b][1,2,4,5]ТЕТРАЗИНЫ, ПРОЯВЛЯЮЩИЕ ПРОТИВООПУХОЛЕВУЮ АКТИВНОСТЬ
US10709715B2 (en) * 2017-12-03 2020-07-14 Cipla Limited Method of treating hypertension
CN113271939B (zh) * 2018-08-09 2025-03-07 伊利诺伊大学董事会 咪唑四嗪化合物
CN114014862A (zh) * 2021-06-28 2022-02-08 烟台大学 一种治疗脑胶质瘤的新化合物及其制备和应用
CN116947765B (zh) * 2022-06-23 2025-10-10 北京新源医疗有限责任公司 一种抗肿瘤药物前药、药物组合物及在肿瘤靶向治疗领域的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8616125D0 (en) * 1986-07-02 1986-08-06 May & Baker Ltd Compositions of matter
UA29466C2 (uk) * 1993-01-14 2000-11-15 Канзер Рісерч Кампейн Технолоджі, Лтд Фармацевтична композиція з антипухлинною активністю
CN1244583C (zh) * 2002-09-29 2006-03-08 天津天士力集团有限公司 替莫唑胺－8－羧酸脂和－8－酰胺衍生物，它们的合成方法以及它们在制备抗癌制剂中的应用
CN1742723A (zh) * 2004-09-02 2006-03-08 天津倍方科技发展有限公司 含有替莫唑胺－8－羧酸酯的药物组合物以及该类化合物用于制备抗肿瘤药物的用途

Also Published As

Publication number Publication date
US20080044457A1 (en) 2008-02-21
MX2007003366A (es) 2008-03-05
RU2393160C2 (ru) 2010-06-27
AU2005287799A1 (en) 2006-03-30
BRPI0515555A (pt) 2008-07-29
JP2008513523A (ja) 2008-05-01
EP1798234A4 (en) 2009-04-29
RU2007114948A (ru) 2008-10-27
CA2580910A1 (en) 2006-03-30
JP2013028630A (ja) 2013-02-07
IL182027A (en) 2014-05-28
ES2389376T3 (es) 2012-10-25
JP5620046B2 (ja) 2014-11-05
PL1798234T3 (pl) 2012-11-30
EP1798234B1 (en) 2012-06-13
WO2006032190A1 (en) 2006-03-30
MY153713A (en) 2015-03-13
KR101065984B1 (ko) 2011-09-19
CA2580910C (en) 2011-10-25
IL182027A0 (en) 2007-07-24
AU2005287799B2 (en) 2009-03-26
HK1100440A1 (en) 2007-09-21
CN1752088A (zh) 2006-03-29
US7579336B2 (en) 2009-08-25
ZA200702801B (en) 2008-08-27
KR20070062569A (ko) 2007-06-15
DK1798234T3 (da) 2012-08-27
AR050947A1 (es) 2006-12-06
NZ554609A (en) 2010-06-25
EP1798234A1 (en) 2007-06-20

Similar Documents

Publication Publication Date Title
AU2018253620A1 (en) Injectable botulinum toxin formulations
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
WO2007145991A3 (en) Anti-inflammatory and analgesic compositions and related methods
UA86614C2 (ru) Соединение, которое имеет активность ингибитора киназ, фармацевтическая композиция, которая включает указанное соединение, и их применение для приготовления лекарственного препарата
WO2006099169A3 (en) Novel liposome compositions
SG158870A1 (en) Bendamustine pharmaceutical compositions for lyophilisation
TW200745111A (en) New compounds
WO2010103544A3 (en) A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants
UA110013C2 (uk) Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів
WO2009109613A3 (en) 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1
NO20043367L (no) Oralt farmasoytisk preparat
PL1819227T3 (pl) Preparat farmaceutyczny decytabiny
TW200510392A (en) Chemical compounds
MX2009006764A (es) Pirimidinonas biciclicas y usos de la misma.
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
WO2009109616A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40
MX2009010165A (es) Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704.
TW200505452A (en) Chemical compounds
AR048336A1 (es) Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
UA89795C2 (ru) Фармацевтическая композиция, которая содержит эстер темозоломида
SG158863A1 (en) Intravenous formulations of pde-5 inhibitors
MX2010004556A (es) Formulacion farmaceutica de acido clavulanico.
WO2010044097A3 (en) Novel dosage form of paliperidone and process for preparing the same
TW200606164A (en) New compounds
TW200800984A (en) New compounds